Carnegie Investment Counsel’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,616
Closed -$265K 592
2025
Q3
$265K Sell
5,616
-40
-0.7% -$1.93K 0.01% 487
2025
Q2
$273K Hold
5,656
0.01% 478
2025
Q1
$314K Buy
+5,656
New +$306K 0.01% 425

Other funds holding SNY

Carnegie Investment Counsel's SNY Position: Q4 2025 in Review

Carnegie Investment Counsel sold out of Sanofi (SNY) in Q4 2025, closing a stake of 5,616 shares — an estimated $265K sold.

Carnegie Investment Counsel first reported a position in SNY in Q1 2025 and held it in 3 quarters. The position peaked at $314K in Q1 2025. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Carnegie Investment Counsel reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Carnegie Investment Counsel sold 5,616 Sanofi shares in Q4 2025, an estimated $265K.
  • Carnegie Investment Counsel first reported a position in Sanofi in Q1 2025 and held it in 3 quarters.
  • Carnegie Investment Counsel's Sanofi position peaked at $314K in Q1 2025.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Carnegie Investment Counsel's 13F filing for Q4 2025, filed 23 Jan 2026.